- Intro, Getting to know Dr. Erin Michos, Pick of the Week
- Patient Case, Digging into ASCVD Risk
- Coronary artery calcium scoring - why it’s important
- What are “Risk Enhancing Factors”?
- Biomarker testing, what is the significance of Lip a and how can we use it to drive management?
- Introduction to PCSK9 inhibitors
- More than just statins - other LDL-lowering medications
- siRNAs, ASOs - Pelacarsen and more
- Apollo Trial regarding Pelacarsen
- Importance of Family History
- What to do if maxed out on a statin or statin intolerance - Ezetimibe, PCSK9 inhibitors, MAB therapies, and more
- Bempedoic Acid discussion
- Medication side effects
- Homozygous FH - approach to treatment, ANGPTL3 inhibitors
- Triglycerides discussion, icosapent ethyl, the REDUCE-IT trial
- Wrap-up and Take home points, Outtro
Credits
- Producer and written by: Christopher Chiu MD, FACP, FAAP
- Show Notes: James Antaki MD
- Infographic: Edison Jyang
- Cover Art: Kate Grant MBChB, DipGUMed
- Hosts: Matthew Watto MD, FACP; Paul Williams MD, FACP
- Associate Editor: Leah Witt MD
- Showrunner: Matthew Watto MD, FACP
- Technical Production: PodPaste
- Guest: Erin Michos MD, MHS